Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-10-030229
Filing Date
2010-05-28
Accepted
2010-05-28 17:12:15
Documents
1
Period of Report
2010-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd276155.html 4  
1 FORM 4 rrd276155.xml 4 3148
  Complete submission text file 0001181431-10-030229.txt   5116
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Issuer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address
Ozeroff Christopher David (Reporting) CIK: 0001454996 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-22873 | Film No.: 10867415